Filing Details
- Accession Number:
- 0000937556-19-000140
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-15 17:56:09
- Reporting Period:
- 2019-07-11
- Accepted Time:
- 2019-07-15 17:56:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403400 | Yongsam Lee | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Evp & Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-11 | 5,339 | $21.97 | 78,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-11 | 5,339 | $151.33 | 73,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-07-12 | 5,989 | $21.97 | 78,989 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-12 | 5,989 | $151.83 | 73,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-07-15 | 1,172 | $21.97 | 74,172 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-15 | 1,172 | $153.98 | 73,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-07-11 | 5,339 | $21.97 | 5,339 | $21.97 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-07-12 | 5,989 | $21.97 | 5,989 | $21.97 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-07-15 | 1,172 | $21.97 | 1,172 | $21.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,161 | 2014-05-28 | 2023-05-28 | No | 4 | M | Direct |
| 6,172 | 2014-05-28 | 2023-05-28 | No | 4 | M | Direct |
| 5,000 | 2014-05-28 | 2023-05-28 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 23, 2019, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $149.19 per share to a high of $152.705 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $150.56 per share to a high of $153.15 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $151.80 per share to a high of $154.905 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on May 28, 2013 and is exercisable as it vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Billionaire Hedge Funds
